Rhythmic and periodic patterns and their association with seizures. The y-axis depicts risk for seizures and the x-axis depicts electroencephalographic pattern frequency. Bilateral independent periodic discharges with Plus were not included but were found to be associated with seizures; however, the sample size was too small to draw firm conclusions. GPDs indicates generalized periodic discharges; GPDs+, generalized periodic discharges with Plus; GRDA+, generalized rhythmic delta activity with Plus; LPDs, lateralized periodic discharges; LPDs+, lateralized periodic discharges with Plus; LRDA, lateralized rhythmic delta activity; LRDA+, lateralized rhythmic delta activity with Plus.
eTable 1. Database Completion Analysis.
eTable 2. Seizures and Pattern Frequency.
eTable 3. Prevalence of EEG Patterns and Association with Seizures.
eTable 4. Association With Seizures in Stimulus Induced Patterns.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Rodriguez Ruiz A, Vlachy J, Lee JW, et al. Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients. JAMA Neurol. 2017;74(2):181–188. doi:https://doi.org/10.1001/jamaneurol.2016.4990
What are the specific characteristics of periodic and rhythmic electroencephalographic patterns that confer risk for seizures?
This multicenter cohort study of 4772 consecutive critically ill adult patients undergoing continuous electroencephalographic monitoring found that lateralized periodic discharges, lateralized rhythmic delta activity, and generalized periodic discharges were associated with seizures, but generalized rhythmic delta activity was not. High frequency and Plus modifier were associated with an additional risk in all patterns except generalized rhythmic delta activity; and increased pattern prevalence was associated with risk for seizures in lateralized periodic discharges and generalized periodic discharges.
A detailed electroencephalographic interpretation using standardized nomenclature can assist seizure risk stratification.
Periodic and rhythmic electroencephalographic patterns have been associated with risk of seizures in critically ill patients. However, specific features that confer higher seizure risk remain unclear.
To analyze the association of distinct characteristics of periodic and rhythmic patterns with seizures.
Design, Setting, and Participants
We reviewed electroencephalographic recordings from 4772 critically ill adults in 3 academic medical centers from February 2013 to September 2015 and performed a multivariate analysis to determine features associated with seizures.
Main Outcomes and Measures
Association of periodic and rhythmic patterns and specific characteristics, such as pattern frequency (hertz), Plus modifier, prevalence, and stimulation-induced patterns, and the risk for seizures.
Of the 4772 patients included in our study, 2868 were men and 1904 were women. Lateralized periodic discharges (LPDs) had the highest association with seizures regardless of frequency and the association was greater when the Plus modifier was present (58%; odds ratio [OR], 2.00, P < .001). Generalized periodic discharges (GPDs) and lateralized rhythmic delta activity (LRDA) were associated with seizures in a frequency-dependent manner (1.5-2 Hz: GPDs, 24%,OR, 2.31, P = .02; LRDA, 24%, OR, 1.79, P = .05; ≥ 2 Hz: GPDs, 32%, OR, 3.30, P < .001; LRDA, 40%, OR, 3.98, P < .001) as was the association with Plus (GPDs, 28%, OR, 3.57, P < .001; LRDA, 40%, P < .001). There was no difference in seizure incidence in patients with generalized rhythmic delta activity compared with no periodic or rhythmic pattern (13%, OR, 1.18, P = .26). Higher prevalence of LPDs and GPDs also conferred increased seizure risk (37% frequent vs 45% abundant/continuous, OR, 1.64, P = .03 for difference; 8% rare/occasional vs 15% frequent, OR, 2.71, P = .03, vs 23% abundant/continuous, OR, 1.95, P = .04). Patterns associated with stimulation did not show an additional risk for seizures from the underlying pattern risk (P > .10).
Conclusions and Relevance
In this study, LPDs, LRDA, and GPDs were associated with seizures while generalized rhythmic delta activity was not. Lateralized periodic discharges were associated with seizures at all frequencies with and without Plus modifier, but LRDA and GPDs were associated with seizures when the frequency was 1.5 Hz or faster or when associated with a Plus modifier. Increased pattern prevalence was associated with increased risk for seizures in LPDs and GPDs. Stimulus-induced patterns were not associated with such risk. These findings highlight the importance of detailed electroencephalographic interpretation using standardized nomenclature for seizure risk stratification and clinical decision making.
Quiz Ref IDContinuous electroencephalographic (cEEG) monitoring is a useful diagnostic tool for identifying seizures and other abnormalities in critically ill patients. Periodic and rhythmic patterns are frequently found in this population and some are known to be associated with seizures.1-8 Standardized terminology has been developed and validated for identifying these patterns, including generalized and lateralized periodic discharges (GPDs and LPDs), generalized and lateralized rhythmic delta activity (GRDA and LRDA), and bilateral independent periodic discharges (BIPDs). A more detailed description of these patterns can be conferred by using various modifiers such as frequency, amplitude, Plus (superimposed fast, rhythmic, or sharp activity), whether the pattern is induced by stimulation, and the prevalence of the pattern9 (Table 1).
The objective of this study was to analyze the association of distinct characteristics of periodic and rhythmic patterns with seizures. Previous studies have demonstrated an association between seizures in specific periodic or rhythmic patterns, but these studies are limited in generalizability because of their small sample sizes.1-5,10-16 They also do not describe the specific features of these patterns that are associated with risk for seizures. To overcome these limitations, we used a large, multicenter database containing detailed descriptions of cEEG recordings and seizure incidence in critically ill patients. We hypothesized that lateralized patterns and patterns with increased frequency and Plus modifier would confer increased risk for seizures.
Using the Critical Care EEG Monitoring Research Consortium multicenter database,17 we collected clinical and electroencephalographic (EEG) data from consecutive critically ill adult patients who underwent cEEG at Brigham and Women’s Hospital, Emory University Hospital, and Yale University Hospital between February 2013 and September 2015. The study was approved by the institutional review boards of each participating center and informed consent was waived because the study was retrospective.
Data entry was performed by attending physicians who were either board certified or board eligible in clinical neurophysiology and clinical neurophysiology fellows with training and certification to use the American Clinical Neurophysiology Society (ACNS) Standardized Critical Care EEG Terminology.9 Individuals were invited to review a training module available at the ACNS website. This was followed by a web-based certification test in which 37 EEG samples were presented. The participants were required to identify detailed EEG features of patterns and seizures from these examples.18 The multicenter data set included demographic factors and the presence of any of the following periodic or rhythmic patterns: LPDs, GPDs, BIPDs, LRDA, and GRDA. Other EEG pattern features included prevalence, duration, typical frequency, number of phases, sharpness, amplitude, polarity, superimposed Plus, fluctuation or evolution, and whether the pattern was stimulus-induced. These terms have been well defined and accepted in previous studies.9 The ACNS terminology does not focus on defining seizures but most practitioners adhere to a form of the Young et al criteria19 or the nonconvulsive status epilepticus definition.20 Previous studies have described seizures as convulsive and nonconvulsive, the latter being the most common in intensive care unit patients.2,21 We considered seizures convulsive if the seizure description was coded in the database as tonic-clonic, tonic, clonic, bilateral convulsive, or myoclonic. We considered seizures nonconvulsive with clinical manifestations if descriptors such as focal sensory, focal motor, complex partial, aphasia, atonic, absence, epileptic spasms, subtle, twitching, stiffening, oral automatism, altered mental status, gaze deviation, blinking, chewing, subtle head movements, behavioral arrest, and confusion were used. Electrographic-only seizures were described if seizures were seen in the EEG with no associated clinical signs. Unknown was defined if the description was not available or was coded as unknown. A more detailed analysis of the interaction of medications, sedatives, paralytics, and other clinical variables with seizures is out of the scope of the present study.
To determine the consistency of data completion, we calculated the percentage of missing data in each of the fields of interest (eTable 1 in the Supplement). Pattern prevalence, typical frequency, and duration were entered reliably (≤30% missing data). There was moderate data completion (30%-50% missing data) for superimposed Plus activity, amplitude, sharpness, fluctuation/evolution, and whether a pattern was stimulus-induced. Polarity, sharpness, amplitude, and number of phases were not reported reliably (>50% missing data). We did not analyze pattern characteristics if more than 50% of the data were missing.
To account for potential day-to-day fluctuations, a pattern was recorded as present if it occurred any time during an individual EEG monitoring session. An EEG monitoring session was defined as contiguous EEG recordings without interruption for longer than 24 hours. The number of patients who underwent EEG monitoring was lower than the total number of EEG monitoring sessions (Table 2). Total EEG monitoring sessions were analyzed instead of total patients to account for individuals who may have undergone repeated EEG monitoring many days or months later, with different risk profiles for seizures. Because pattern frequency may fluctuate within a given monitoring session, we selected the maximal recorded frequency for any given pattern within that session.
The data were analyzed using the open source statistical package R (R Foundation for Statistical Computing).22 Differences in patient age and duration of EEG monitoring sessions were calculated using the Kruskal–Wallis rank sum test. Several multivariate logistic regression models were estimated, controlling for age, sex, institution, and diagnosis. In these models, patients with specific periodic or rhythmic patterns were compared with patients without these patterns while controlling for all other major patterns to evaluate an association between the pattern and seizure occurrence. For all the models, the estimated odds ratios and 95% CIs were presented. Adjusted P values to control false discovery rate were calculated using the method described by Benjamini et al.23 For statistical significance, a certainty level of α = .05 was used. The interquartile range was used to measure variability in the patient sessions.24
A total of 4772 patients underwent cEEG for a total of 5742 sessions across 3 centers during the study. The median time between sessions was 25.3 hours and an interquartile range of 18.0 to 46.9 hours. Most patients were recorded for more than 12 hours. The incidence of seizures and periodic or rhythmic patterns was similar among the 3 centers as well as primary neurological diagnoses (Table 2). The percentage of male patients ranged between 47.6% and 51.6% and the median patient age was between 59 and 63 years. We identified 2344 sessions (41%) with at least 1 type of periodic or rhythmic pattern. Seizures were documented in 719 sessions (12.5%), of which 530 (74%) also had a periodic or rhythmic pattern. There were 3427 sessions with no periodic or rhythmic patterns in which 202 patients had seizures (6%). There were 1739 seizures recorded in which 183 (10.5%) were convulsive, 471 (27.1%) nonconvulsive with clinical manifestations, 865 (49.7%) electrographic only, and 220 (12.7%) unknown/unclassified.
Regardless of consideration of frequency or Plus, LPDs, LRDA, GPDs, and BIPDs were associated with seizures while GRDA was not (Table 3). Compared with EEG sessions with no rhythmic or periodic pattern present, LPDs and LRDA without Plus were associated with seizure risk, which increased when a Plus modifier was present (Table 3). Generalized periodic discharges with Plus modifier were associated with seizures but GPDs without Plus were not. There was a trend toward BIPDs with Plus being associated with seizures while GRDA was not, regardless of whether a Plus modifier was present. There was also an additional risk of seizures when a particular pattern contained a Plus modifier compared with the same pattern without a modifier: LPDs with Plus vs without (odds ratio, 2.00, 95% CI, 1.44-2.78, P < .001) and GPDs with Plus vs without (odds ratio, 2.66, 95% CI, 1.59-4.41, P < .001). Although the odds ratio for seizures was higher in patients with LRDA Plus compared with LRDA alone, it failed to meet statistical significance (odds ratio, 1.85, 95% CI, 1.07-3.23, P = .06). The presence of a Plus modifier did not confer any difference in seizure risk for patients with GRDA (P = .25, 95% CI, 0.38-1.15). There were no significant changes in these findings when patients were Plus and were not coded or left blank (not applicable, data not shown).
To determine whether pattern frequency conferred particular risk for seizures, we divided each pattern into 4 frequency bands—less than 1.5 Hz, 1.5 to less than 2 Hz, greater than or equal to 2 Hz, and frequency not recorded—and evaluated the association with seizures (Table 4). Lateralized periodic discharges were associated with seizures at any frequency with seizure risk greatest at higher frequencies. The risk of seizures was also frequency-dependent for LRDA and GPDs, but only frequencies of 1.5 Hz or greater were associated with seizures. Quiz Ref IDGeneralized rhythmic delta activity was not associated with seizures at any frequency. The sample size was too small to study the effect of individual frequencies for BIPDs.
Given the paucity of patterns classified at higher frequencies (≥2.5 Hz), we hypothesized that these patterns were not being recorded as periodic or rhythmic patterns but instead were considered electrographic seizures. To test this hypothesis, we compared frequency bands of various periodic and rhythmic patterns with the minimum and maximum frequency of any electrographic seizures recorded during the same sessions as the patterns (eTable 2 in the Supplement). Although there is often an overlap between pattern frequency and minimum seizure frequency, there was little overlap with maximum seizure frequency. Therefore, it is unlikely that patterns with frequencies in the 2- to 3-Hz range were being recorded as electrographic seizures instead of a periodic or rhythmic pattern.
To determine the influence of pattern prevalence on seizure risk, each pattern was divided into the following categories according to ACNS Standardized Critical Care EEG Terminology9: rare/occasional (up to 9% of the recording), frequent (10%-49% of the recording), and abundant/continuous (50%-89% of the recording). There was a positive correlation between increasing prevalence and incidence of seizures for GPDs (rare/occasional vs frequent and frequent vs abundant/continuous, 95% CI, 1.31-5.81 and 95% CI, 1.14-3.40, respectively) and LPDs (frequent vs abundant/continuous; 95% CI, 1.13-2.41) (all P < .05) (eTable 3 in the Supplement).
We analyzed whether seizure risk changed if a particular pattern was induced by stimulation. We did not detect a significant difference in the incidence of seizures when comparing spontaneously appearing patterns with the same type of pattern that emerged before stimulation (eTable 4 in the Supplement). However, this may be caused by sample size. Although the number of sessions of patients with stimulation-induced pattern was adequate (range, 21-127), the number of sessions of patients with stimulation-induced pattern and seizures was small (range, 6-30).
This study demonstrates the association between periodic and rhythmic patterns and seizures in critically ill patients, including which patterns are dependent on specific features (Figure). Quiz Ref IDSpecifically, LPDs were highly associated with seizures regardless of whether particular features were present, and seizure risk increased with higher frequencies, Plus modifier, and higher pattern prevalence. Similarly, LRDA was also highly associated with seizures with increased risk when Plus was present, and a frequency-dependent association was seen at 1.5 Hz and higher. Generalized periodic discharges only confer seizure risk at frequencies of 1.5 Hz and faster when associated with a Plus modifier and at higher pattern prevalence. Comparing all sessions with BIPDs with sessions with no patterns revealed a trend toward association with seizures, but the small sample size did not allow for analysis of specific features. There was also an association between increasing pattern prevalence and risk of seizures for GPDs and LPDs. Most of the seizures were nonconvulsive, similar to previous studies.1-3 Finally, there was no association between GRDA and seizures regardless of pattern characteristics.
These findings are concordant with previous studies. Chatrian et al8 reported seizures in 88% of their participants with periodic lateralized epileptiform discharges (PLEDs) and acute focal lesions or history of chronic focal epilepsy. Similarly, Snodgrass et al25 reported seizures in 126 of 147 patients (86%) with PLEDs on routine EEG. In 2002, García-Morales et al5 reported focal seizures in 50% of patients with PLEDs. It is important to note that most of these older studies were based on routine EEGs. Our study also supports Gaspard et al1 who demonstrated that LRDA was highly associated with seizures at an incidence similar to LPDs. That study reported that 17 of 27 patients (62%) with LRDA had seizures, while 57% of patients with LPDs experienced seizures. They also showed a trend toward increased risk of seizures when the LRDA was associated with superimposed spikes/sharps.
To our knowledge, the clinical significance of periodic or rhythmic patterns associated with admixed fast, rhythmic, or sharp activity (the Plus modifiers) has not been extensively explored in prior studies. Reiher et al12 were the first to describe “PLEDs Plus” as typical PLEDs (termed PLEDs Proper) with superimposed fast activity. They found PLEDs Plus was more frequently associated with seizures and status epilepticus than PLEDs proper. Quiz Ref IDOur study provides evidence that periodic and rhythmic patterns associated with Plus (as defined by the ACNS Standardized Critical Care EEG Terminology as superimposed fast, rhythmic, or sharp activity9) confers an additional risk for seizures in patients with LPDs, LRDA, and GPDs.
In 2004, Hirsch et al11 described rhythmic and periodic patterns that are induced by stimulation (termed stimulus induced rhythmic, periodic, or ictal discharges) and demonstrated an association with seizures in 50% of patients. Smaller series have verified the association of stimulus-induced rhythmic, periodic, or ictal discharges and seizures.13,26 However, a key unanswered question is whether stimulus-induced patterns are more or less associated with seizures than the spontaneous appearance of the periodic or rhythmic pattern. In this study, there was no significant difference in the incidence of seizures when patterns were stimulus-induced compared with spontaneously occurring patterns, but this finding is limited because of the small number of patients with stimulus-induced patterns. Further studies should be performed to find better characterizations.
We described the influence of pattern frequency on seizure risk. After controlling for other variables, such as the Plus modifiers, we found that seizure risk is only linked to frequency for some patterns. In patients with GPDs and LRDA, frequencies of 1.5 Hz or more were highly associated with seizures, but there was no association less than 1.5 Hz. In a recent study by Foreman et al,3 GPDs were found to be highly associated with focal and generalized nonconvulsive seizures in critically ill patients (46.4% and 66.1%, respectively), but that study did not evaluate individual frequencies. Our study suggests that the association between GPDs and seizures is primarily seen at higher frequencies. Patients with LPDs were the only group in which seizure risk was high regardless of frequency, but there was still a frequency-dependent increase in seizure risk.
Finally, this study provides important information about GRDA. Generalized rhythmic delta activity was not associated with seizures, even when associated with Plus, stimulation induction, increasing frequencies, or prevalence. Before the standardized EEG classification system was published by ACNS, GRDA was largely known as frontal intermittent rhythmic delta activity, initially described by Cobb27 in 1945. This pattern has been associated with numerous brain pathologies such as metabolic impairment (most common), midline brain lesions, subcortical lesions, Creutzfeldt-Jakob disease, diffuse Lewy body disease, and epilepsy.28 In a study of frontal intermittent rhythmic delta activity in routine EEGs of patients with chronic epilepsy, this pattern was found only in 2%,29 which is consistent with our finding of no association between GRDA and seizures.
There was an association between BIPDs and seizures in our data set. De la Paz and Brenner30 described seizures in 78% of 18 patients with BIPDs during an acute illness. Snodgrass et al25 described BIPDs in 10% of 147 patients with clinical diagnosis of cardiac arrest, central nervous system infections, and chronic epilepsy, including 4 patients following status epilepticus. Our cohort suggests that BIPDs may confer an increased association with seizures, but detailed characterization of this group was limited because of the small sample size.
We found that increasing pattern prevalence increases the risk for seizures in LPDs and GPDs. This may influence clinical practice because it suggests that each pattern’s burden within a record is an important determinant of the risk for seizures. Furthermore, it supports cEEG use in the intensive care unit because it provides increased sampling to estimate pattern prevalence.
This study has several limitations. First, the retrospective nature of the study introduces selection bias toward patients in whom clinicians had reason to order cEEG and may not accurately reflect the true frequency of various patterns and seizures than if the study was performed in all patients. Second, the small sample size of patients with BIPDs and stimulation-induced patterns limits the interpretation of our findings in these patients. Third, this study does not account for interactions between multiple EEG patterns when they occur together or when 1 pattern evolves to another. Fourth, we did not account for potential effects of antiepileptic medications or sedatives on the incidence of these patterns and seizures, which will be studied separately. Fifth, there were substantial missing data elements in this cohort because this database was primarily used for clinical reporting rather than research purposes. However, we do not feel that this affects our conclusions regarding periodic and rhythmic patterns because no systematic biases were found.
This study represents a large multicenter retrospective analysis of periodic and rhythmic patterns and their effect on seizure risk. Quiz Ref IDThe data support increased seizure risk in association with LPDs, LRDA, and GPDs and emphasize the importance of standardized identification and classification of these patterns and their specific features. Knowledge of these specific features can help physicians judge which patients should be monitored and treated more aggressively instead of indiscriminately monitoring or treating all patients who present with periodic/rhythmic patterns. Furthermore, it will provide a more cost-effective use of EEG monitoring resources.
Corresponding Author: Andres Rodriguez Ruiz, MD, Emory University School of Medicine, 12 Executive Park, Ste 250, Atlanta, GA 30329 (firstname.lastname@example.org).
Accepted for Publication: October 11, 2016.
Published Online: December 19, 2016. doi:10.1001/jamaneurol.2016.4990
Author Contributions: Dr Rodriguez Ruiz had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Rodriguez Ruiz, Lee, Hirsch, LaRoche.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Rodriguez Ruiz, Vlachy, Ayer, LaRoche.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Rodriguez Ruiz, Vlachy, Ayer.
Administrative, technical, or material support: Rodriguez Ruiz, Lee, Fantaneanu, LaRoche.
Supervision: Hirsch, LaRoche.
Conflict of Interest Disclosures: Dr Rodriguez Ruiz received funding from Neuropace to attend a conference and research funding from Optima Neuroscience Inc with the project funded by grant 2R44NS064647-05A1 (National Institute of Neurological Disorders and Stroke [NINDS]) and Sage Therapeutics Inc. Dr Lee received research funding from NINDS and UCB and consultant fees from Advance Medical and SleepMed/DigiTrace. Dr Gilmore is supported by grants ULTR000142 CTSA (Yale University Center for Clinical Investigation) and P30AG021342 from the National Institutes of Health/National Institute on Aging, Yale University Claude D. Pepper Older Americans Independence Center, the American Brain Foundation, and the National Institute of Health’s Loan Repayment Program, and she also receives royalties from Jaypee Brothers Medical Publishers. Dr Haider was supported by Research Education Training grant R25 from NINDS and received royalties from UpToDate Inc. Dr Gaspard is a clinical master specialist of the Fonds de la Recherche Scientifique and received research funding from the Fonds Erasme pour le Recherche Médicale. Dr Tolchin receives research funding from the American Academy of Neurology/American Brain Foundation. Dr Hirsch has received research funding from Upsher-Smith, Lundbeck, Eisai, Sunovion, and Acorda; consulting fees from Upsher-Smith, Neuropace, Marinus, Monteris, Sunovion, and Ceribell; and royalties from UpToDate-Neurology, Medlink-Neurology, and Wiley for coauthoring the book Atlas of EEG in Critical Care. Dr Hirsch spends about 25% of his clinical billable time implementing and interpreting critical care EEG studies. Dr LaRoche receives royalties from Demos Publishing. No other disclosures were reported.
Funding/Support: This study was supported by a Research Infrastructure award from the American Epilepsy Society and the Epilepsy Foundation.
Role of the Funder/Sponsor: The American Epilepsy Society and the Epilepsy Foundation had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The Critical Care EEG Monitoring Research Consortium principal investigators were Chinasa Nwankwo, MD, Akron Children’s Hospital, Akron, Ohio; Jeffrey Politsky, MD, Atlantic Health System, Summit, New Jersey; Susan T. Herman, MD, Beth Israel Deaconess Medical Center, Boston; Tobias Loddenkemper, MD, Boston Children’s Hospital, Boston, Massachusetts; Linda Huh, MD, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada; Jong Woo Lee, MD, PhD, Brigham and Women’s Hospital, Boston, Massachusetts; Nicholas S. Abend, MD, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; Jessica Carpenter, MD, Children’s National Medical Center, Washington, DC; Stephen Hantus, MD, Cleveland Clinic Epilepsy Center, Cleveland, Ohio; Jan Claassen, MD, PhD, Columbia University Medical Center, New York, New York; Aatif M. Husain, MD, Duke University Medical Center, Durham, North Carolina; Andres Ruiz Rodriguez, MD, Emory University School of Medicine, Atlanta, Georgia; Nicolas Gaspard, MD, PhD, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Cecil D. Hahn, MD, MPH, The Hospital for Sick Children, Toronto, Ontario, Canada; David Gloss, MD, Geisinger Medical Center, Danville, Pennsylvania; Eva K. Ritzl, MD, Johns Hopkins University, Baltimore, Maryland; Tennile Gofton, MD, London Health Science Centre, London, England; Joshua Goldstein, MD, Lurie Children’s Hospital, Chicago, Illinois; Brandon M. Westover, MD, PhD, Massachusetts General Hospital, Boston, Massachusetts; Sara Hocker, MD, Mayo Clinic, Rochester, New Jersey; Jonathan Halford, MD, Medical University of South Carolina, Charleston; Suzette M. LaRoche, MD, Mission Hospital, Asheville, North Carolina; Ann Hyslop, MD, Nicklaus Children’s Hospital, Miami, Florida; Elizabeth E. Gerard, MD, Northwestern University, Chicago, Illinois; Korwyn Williams, MD, PhD, Phoenix Children’s Hospital, Phoenix, Arizona; Xiuhua Bozarth, MD, PhD, Seattle Children’s Hospital, Seattle, Washington; Andres Fernandez, MD, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania; Jerzy P. Szaflarski, MD, PhD, University of Alabama at Birmingham; Andreas Kramer, MD, University of Calgary, Calgary, Alberta, Canada; Brandon Foreman, MD, University of Cincinnati, Cincinnati, Ohio; Pearce Korb, MD, University of Colorado, Boulder; Leslie Rudzinski, MS, University of Florida, Gainesville; Rup Sainju, MD, University of Iowa Carver School of Medicine, Iowa City; Jennifer Hopp, MD, University of Maryland School of Medicine, College Park; Ram Mani, MD, University of Medicine and Dentistry of New Jersey, Newark; Kathryn A. Davis, MD, University of Pennsylvania, Philadelphia; Giridhar P. Kalamangalam, MD, University of Texas Health Science Center, San Antonio; Kan Ding, MD, University of Texas Southwestern Medical Center, Dallas; Mark S. Quigg, MD, University of Virginia School of Medicine, Charlottesville, Virginia; Kevin F. Haas, Vanderbilt University, Nashville, Tennessee; Adam Ostendorf, MD, Washington University in St. Louis, Missouri; Deepti Zutshi, MD, Wayne State University Detroit Medical Center, Detroit, Michigan; Kim Pargeon, MD, Weill Cornell Medical Center, Ithaca, New York; and Lawrence J. Hirsch, MD, Yale University, New Haven, Connecticut.
Additional Contributions: This study acknowledges all the neurology/epilepsy faculty, residents, and technicians from Brigham and Women’s Hospital, Emory University Hospital, and Yale University Hospital who contributed to the data collection and technical support of the study. We thank Michael Konomos, MS, CMI, from Emory University for graphical design support for the medical figure. Mr Konomos did not claim any compensation for his services. Written permission was obtained from the authors and contributors of this work.
Create a personal account or sign in to: